1. Corso G, Velho S, Paredes J, Pedrazzani C, Martins D, Milanezi F, Pascale V, Vindigni C, Pinheiro H, Leite M, Marrelli D, Sousa S, Carneiro F, Oliveira C, Roviello F, Seruca R

Oncogenic mutations in gastric cancer with microsatellite instability. European journal of cancer (Oxford, England : 1990) 47: 443-51, 2011.  [Article] 

 doi: 10.1016/j.ejca.2010.09.008 PMID: 20937558.

 

2. Martins D, Beça FF, Sousa B, Baltazar F, Paredes J, Schmitt F

Loss of caveolin-1 and gain of MCT4 expression in the tumor stroma: Key events in the progression from an in situ to an invasive breast carcinoma. Cell cycle (Georgetown, Tex.) 12: 2684-90, 2013.  [Article] 

 doi: 10.4161/cc.25794 PMID: 23907124.

 

3. Gullo I, Carvalho J, Martins D, Lemos D, Monteiro AR, Ferreira M, Das K, Tan P, Oliveira C, Carneiro F, Oliveira P

The Transcriptomic Landscape of Gastric Cancer: Insights into Epstein-Barr Virus Infected and Microsatellite Unstable Tumors. International journal of molecular sciences 19: ., 2018.  [Article] 

 doi: 10.3390/ijms19072079 PMID: 30018250.

 

4. Sousa B, Ribeiro AS, Nobre AR, Lopes N, Martins D, Pinheiro C, Vieira AF, Albergaria A, Gerhard R, Schmitt F, Baltazar F, Paredes J

The basal epithelial marker P-cadherin associates with breast cancer cell populations harboring a glycolytic and acid-resistant phenotype. BMC cancer 14: 734, 2014.  [Article] 

 doi: 10.1186/1471-2407-14-734 PMID: 25269858.

 

5. Lopes N, Sousa B, Martins D, Gomes M, Vieira D, Veronese LA, Milanezi F, Paredes J, Costa JL, Schmitt F

Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions Vitamin D pathways unbalanced in breast lesions. BMC cancer 10: 483, 2010.  [Article] 

 doi: 10.1186/1471-2407-10-483 PMID: 20831823.

 

6. Beca F, Andre R, Martins DS, Bilhim T, Martins D, Schmitt F

p-mTOR expression is associated with better prognosis in luminal breast carcinoma. Journal of clinical pathology 67: 961-7, 2014.  [Article] 

 doi: 10.1136/jclinpath-2014-202320 PMID: 25053543.

 

7. Martins D, Sousa B, Lopes N, Gomes M, Veronese L, Albergaria A, Paredes J, Schmitt F

Molecular phenotypes of matched in situ and invasive components of breast carcinomas. Human pathology 42: 1438-46, 2011.  [Article] 

 doi: 10.1016/j.humpath.2010.08.024 PMID: 21450330.

 

8. Sousa B, Paredes J, Milanezi F, Lopes N, Martins D, Dufloth R, Vieira D, Albergaria A, Veronese L, Carneiro V, Carvalho S, Costa JL, Zeferino L, Schmitt F

P-cadherin, vimentin and CK14 for identification of basal-like phenotype in breast carcinomas: an immunohistochemical study. Histology and histopathology 25: 963-74, 2010.  [Article] 

 PMID: 20552547.

 

9. Martins D, Beca F, Schmitt F

Metastatic breast cancer: mechanisms and opportunities for cytology. Cytopathology : official journal of the British Society for Clinical Cytology 25: 225-30, 2014.  [Review] 

 doi: 10.1111/cyt.12158 PMID: 24889678.

 

10. Dufloth RM, Alves JM, Martins D, Vieira DS, Chikota H, Zeferino LC, Schmitt F

Cytological criteria to predict basal phenotype of breast carcinomas. Diagnostic cytopathology 37: 809-14, 2009.  [Article] 

 doi: 10.1002/dc.21102 PMID: 19431201.

 

11. Faria G, Cardoso MJ, Martins D, Bettencourt H, Amendoeira I, Schmitt F

P-cadherin as prognostic factor for loco-regional relapse in breast cancer. Acta medica portuguesa 25: 97-105, 2012.  [Article] 

 PMID: 22985920.